RBC Capital Keeps Their Buy Rating on Repligen (RGEN)

23 hours ago · RBC Capital analyst Conor McNamara maintained a Buy rating on Repligen (RGEN – Research Report) on January 10 and set a price target of $207.00. The company’s …

$207.00
OFF

RBC Capital Keeps Their Buy Rating On Repligen (RGEN)

2 weeks from now

23 hours ago · RBC Capital analyst Conor McNamara maintained a Buy rating on Repligen (RGEN – Research Report) on January 10 and set a price target of $207.00. The company’s …

businessinsider.com

51%
OFF

RGEN Stock Price | Repligen Corp. Stock Quote (U.S.: Nasdaq ...

2 weeks from now

Jan 7, 2025 · RBC Capital Reaffirms Their Buy Rating on Repligen (RGEN) Dec. 10, 2024 at 8:45 p.m. ET on TipRanks.com Repligen Corp (RGEN) Shares Up 3.51% on Dec 9

marketwatch.com

$207
OFF

RBC Lifts Price Target On Repligen To $207 From $205, Keeps …

2 weeks from now

Dec 9, 2024 · -- Repligen has an average rating of overweight and mean price target of $193.25, according to analysts polled by FactSet. ...

marketscreener.com

$190
OFF

Repligen Corporation: Target Price Consensus And Analysts ...

2 weeks from now

13 hours ago · RGEN US7599161095 Medical Equipment, Supplies & Distribution ... UBS Adjusts Price Target on Repligen to $190 From $185, Keeps Buy Rating Nov. 13: MT RBC Raises …

marketscreener.com

$207
OFF

Repligen Corporation Presents At 43rd Annual J.P. Morgan …

2 weeks from now

5 hours ago · RBC Lifts Price Target on Repligen to $207 From $205, Keeps Outperform Rating ... UBS Adjusts Price Target on Repligen to $190 From $185, Keeps Buy Rating Nov. 13: MT …

marketscreener.com

50%
OFF

North Bergen High School - Public School Review

2 weeks from now

Serving 2,355 students in grades 9-12, North Bergen High School ranks in the bottom 50% of all schools in New Jersey for overall test scores (math proficiency is bottom 50%, and reading …

publicschoolreview.com

$205.00
OFF

Repligen (RGEN) Receives A Buy From RBC Capital

2 weeks from now

Sep 25, 2024 · RBC Capital analyst Conor McNamara maintained a Buy rating on Repligen (RGEN – Research Report) on September 22 and set a price target of $205.00. The …

businessinsider.com

$2
OFF

RBC Capital Sticks To Their Buy Rating For Repligen (RGEN)

2 weeks from now

Jan 26, 2024 · RBC Capital analyst Conor McNamara maintained a Buy rating on Repligen (RGEN – Research Report) on January 24 and set a price target of $2...

businessinsider.com

FAQs about RBC Capital Keeps Their Buy Rating on Repligen (RGEN) Coupon?

Is Repligen (RGEN) a good investment opportunity?

Despite Repligen's (NASDAQ:RGEN) stock declining 17% over the past three months, the company's fundamentals look decent. Long-term financials are usually aligned with future market price movements. ...

Should you buy Repligen (Repligen) stock?

McNamara covers the Healthcare sector, focusing on stocks such as Illumina, Repligen, and Danaher. According to TipRanks, McNamara has an average return of -10.6% and a 32.87% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Repligen with a $194.25 average price target. ...

Where is Repligen headquartered?

It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA. RGEN | Complete Repligen Corp. stock news by MarketWatch. ...

What does Repligen do?

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. ...